UCB

Biotechnology, Health Care, Pharmaceutical
Founded in 1/1/28
Brussels, Brussels Hoofdstedelijk Gewest, Belgium
http://www.ucb.com
For Profit

About UCB

UCB Pharma operates as a biopharmaceutical company with a focus on neurology and immunology diseases. The company leverages scientific advances and skills in areas such as genetics, biomarkers, and human biology.

Company Metrics

  • Employees: 10001+
  • Monthly Visits: 106839
  • Tech Stack: 43 active products

Financial Information

  • Estimated Revenue: $1B to $10B
  • Total Funding: 202213820 USD
  • Last Funding: 94500000 EUR (Post-IPO Equity)
  • Funding Status: IPO

Technology Stack

UCB actively uses 43 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Pharmaceutical

Headquarters: Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Leadership

  • Gau Rav - ceo LinkedIn
  • Imane Wild - CEO/CMO LinkedIn
  • Jean-Christophe Tellier - CEO LinkedIn
  • Cathy Vandenbril - Global Strategy and Operations Lead for Legal - Enterprise Risk Management Partner (director) LinkedIn
  • Conrad - Associate Director, IT Business Partner, Commercial & Medical Systems LinkedIn
  • Fabian Englebert - associate director, CMO Management Pharma LinkedIn
  • Federica Toso - HR Director - Talent Partner Europe Epi Strategic Operation & Country Italy at UCB LinkedIn
  • Hoang-Hai Bui - Director, Finance Business Partner Bio/Pharma Sciences Development (CMC) LinkedIn
  • Khatera Alawi - HR Director Germany and Global Talent Partner R&D LinkedIn
  • Michele Ehler - Director, Talent Partner US LinkedIn